The effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgery

Background and Aims: Antifibrinolytics may help bleeding in orthopaedic surgeries. The present study was undertaken to compare two dose regimens of tranexamic acid (TA) on perioperative blood loss in patients undergoing hip surgeries. Methods: In a prospective, randomised, controlled study, 59 patie...

Full description

Bibliographic Details
Main Authors: Anil Kumar Thipparampall, Indira Gurajala, R Gopinath
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Anaesthesia
Subjects:
Online Access:http://www.ijaweb.org/article.asp?issn=0019-5049;year=2017;volume=61;issue=3;spage=235;epage=239;aulast=Thipparampall
_version_ 1828544523337203712
author Anil Kumar Thipparampall
Indira Gurajala
R Gopinath
author_facet Anil Kumar Thipparampall
Indira Gurajala
R Gopinath
author_sort Anil Kumar Thipparampall
collection DOAJ
description Background and Aims: Antifibrinolytics may help bleeding in orthopaedic surgeries. The present study was undertaken to compare two dose regimens of tranexamic acid (TA) on perioperative blood loss in patients undergoing hip surgeries. Methods: In a prospective, randomised, controlled study, 59 patients scheduled for hip surgery were divided into Group C: receiving normal saline (n - 20), Group B: receiving single dose of TA (10 mg/kg) (n - 21), and Group I: receiving a bolus (10 mg/kg) plus infusion (1 mg/kg/h) of TA up to 4 h postoperatively (n - 18). Blood loss, haemoglobin and allogeneic blood transfusions were compared between the groups. For parametric data, P was calculated by ANOVA. Intergroup comparison was done by post hoc analysis with Bonferroni test. P < 0.05 was considered significant. Results: The intra-operative blood loss was lower in the patients who received TA (525 ± 150, 456 ± 156 and 400 ± 133 ml in Group C, B and I respectively; P = 0.05). The 6th hourly drain collection in Group I was lower than Group B and C (41 ± 18, 46 ± 14 and 31 ± 14 ml in Group C, B, and I respectively; P = 0.018). The blood loss at 24 h was less in groups receiving TA (146 ± 32, 120 ± 76, 107 ± 37 ml for Group C, B and I, respectively; P = 0.02). The requirement of blood transfusions was lower in Group I. Conclusions: A bolus of tranexamic acid followed by infusion is more useful than a single dose in decreasing perioperative blood loss in patients undergoing hip surgeries. It reduces allogenic blood transfusion without increasing risk of thromboembolic events.
first_indexed 2024-12-12T02:32:18Z
format Article
id doaj.art-a316a352f5af46e8a6767d4caedf60ac
institution Directory Open Access Journal
issn 0019-5049
0976-2817
language English
last_indexed 2024-12-12T02:32:18Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Anaesthesia
spelling doaj.art-a316a352f5af46e8a6767d4caedf60ac2022-12-22T00:41:23ZengWolters Kluwer Medknow PublicationsIndian Journal of Anaesthesia0019-50490976-28172017-01-0161323523910.4103/ija.IJA_495_16The effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgeryAnil Kumar ThipparampallIndira GurajalaR GopinathBackground and Aims: Antifibrinolytics may help bleeding in orthopaedic surgeries. The present study was undertaken to compare two dose regimens of tranexamic acid (TA) on perioperative blood loss in patients undergoing hip surgeries. Methods: In a prospective, randomised, controlled study, 59 patients scheduled for hip surgery were divided into Group C: receiving normal saline (n - 20), Group B: receiving single dose of TA (10 mg/kg) (n - 21), and Group I: receiving a bolus (10 mg/kg) plus infusion (1 mg/kg/h) of TA up to 4 h postoperatively (n - 18). Blood loss, haemoglobin and allogeneic blood transfusions were compared between the groups. For parametric data, P was calculated by ANOVA. Intergroup comparison was done by post hoc analysis with Bonferroni test. P < 0.05 was considered significant. Results: The intra-operative blood loss was lower in the patients who received TA (525 ± 150, 456 ± 156 and 400 ± 133 ml in Group C, B and I respectively; P = 0.05). The 6th hourly drain collection in Group I was lower than Group B and C (41 ± 18, 46 ± 14 and 31 ± 14 ml in Group C, B, and I respectively; P = 0.018). The blood loss at 24 h was less in groups receiving TA (146 ± 32, 120 ± 76, 107 ± 37 ml for Group C, B and I, respectively; P = 0.02). The requirement of blood transfusions was lower in Group I. Conclusions: A bolus of tranexamic acid followed by infusion is more useful than a single dose in decreasing perioperative blood loss in patients undergoing hip surgeries. It reduces allogenic blood transfusion without increasing risk of thromboembolic events.http://www.ijaweb.org/article.asp?issn=0019-5049;year=2017;volume=61;issue=3;spage=235;epage=239;aulast=ThipparampallBlood losship surgeriestranexamic acid
spellingShingle Anil Kumar Thipparampall
Indira Gurajala
R Gopinath
The effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgery
Indian Journal of Anaesthesia
Blood loss
hip surgeries
tranexamic acid
title The effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgery
title_full The effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgery
title_fullStr The effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgery
title_full_unstemmed The effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgery
title_short The effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgery
title_sort effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgery
topic Blood loss
hip surgeries
tranexamic acid
url http://www.ijaweb.org/article.asp?issn=0019-5049;year=2017;volume=61;issue=3;spage=235;epage=239;aulast=Thipparampall
work_keys_str_mv AT anilkumarthipparampall theeffectofdifferentdoseregimensoftranexamicacidinreducingbloodlossduringhipsurgery
AT indiragurajala theeffectofdifferentdoseregimensoftranexamicacidinreducingbloodlossduringhipsurgery
AT rgopinath theeffectofdifferentdoseregimensoftranexamicacidinreducingbloodlossduringhipsurgery
AT anilkumarthipparampall effectofdifferentdoseregimensoftranexamicacidinreducingbloodlossduringhipsurgery
AT indiragurajala effectofdifferentdoseregimensoftranexamicacidinreducingbloodlossduringhipsurgery
AT rgopinath effectofdifferentdoseregimensoftranexamicacidinreducingbloodlossduringhipsurgery